BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS

被引：0
|
作者：
Takkenberg, Bart [1 ,2 ]
Zaaijer, Hans L. [3 ,4 ]
de Niet, Annikki [1 ,2 ]
Weegink, Christine J. [1 ,2 ]
Terpstra, Valeska [5 ]
Koot, Maarten [7 ]
Dijkgraaf, Marcel [6 ]
Jansen, Peter L. [1 ,2 ]
Janssen, Harry L. [8 ]
Beld, Marcel [9 ]
Reesink, Hendrik W. [1 ,2 ]
机构：
[1] AMC Liver Ctr, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Med Microbiol & Karl Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[4] Ctr Infect Dis & Immunol CINIMA, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[7] Sanquin, Dept Virus Diagnost Serv, Amsterdam, Netherlands
[8] Erasmus MC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[9] KIT Biomed Res, Amsterdam, Netherlands
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
488
引用
收藏
页码：536A / 537A
页数：2
相关论文
共 50 条
  • [21] A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B
    Chan, H. L. Y.
    Messinger, D.
    Papatheodoridis, G. V.
    Cornberg, M.
    Xie, Q.
    Piratvisuth, T.
    Ren, H.
    Kennedy, P. T.
    Thompson, A.
    Caputo, A.
    Bakalos, G.
    Pavlovic, V.
    Lampertico, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (05) : 547 - 555
  • [22] HBsAg loss in HBeAg positive and HBeAg negative patients with chronic HBV treated with Tenofovir disoproxil
    Tuzcuoglu, Isil
    Sungur, Murvet
    Acilar, Kemal
    Kurt, Kamile
    Gokmen, Tulay
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 648 - 649
  • [23] ON-TREATMENT HBSAG LEVEL AND HBEAG INDEX CAN EARLY PREDICT HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B, HBEAG POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2A
    Phisalprapa, Pochamana
    Charatcharoenwitthaya, Phunchai
    Chainuvati, Siwaporn
    Nimanong, Supot
    Prachayakul, Varayu
    Pausawasdi, Nonthalee
    Pongprasobchai, Supot
    Leelakusolvong, Somchai
    Manatsathit, Sathaporn
    Kachintorn, Udom
    Tanwandee, Tawesak
    HEPATOLOGY, 2010, 52 (04) : 526A - 527A
  • [24] On-treatment HBsAg level and HBeAg index can early predict HBeAg seroconversion in chronic hepatitis B, HBeAg positive patients treated with peginterferon alpha-2a
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Nimanong, S.
    Pausawasdi, N.
    Prachayakul, V.
    Pongprasobchai, S.
    Udompanthurak, S.
    Leelakusolvong, S.
    Manatsathit, S.
    Kachintorn, U.
    Tanwandee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A94 - A94
  • [25] Predicting response to peginterferon alfa-2a (40 KD) (PEGASYS®) in Asian patients with HBeAg-positive chronic hepatitis B
    Cooksley, Graham
    Chow, Wan Cheng
    Piratvisuth, Teerha
    Lau, George K. K.
    Mccloud, Philip
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A108 - A108
  • [26] Baseline and early on-treatment HBsAg level to predict HBsAg loss in nucleotide analog suppressed and HBeAg cleared chronic hepatitis B patients by switching to peginterferon alfa-2a: exploratory results of NEW SWITCH study
    Hu, P.
    Xie, Q.
    Li, Y.
    Chen, X.
    Dou, X.
    Jiang, J.
    Shang, J.
    Zhang, W.
    Gong, G.
    Sun, Y.
    Li, Y.
    Liu, Y.
    Liu, G.
    Mao, D.
    Chi, X.
    Tang, H.
    Li, X.
    Xie, Y.
    Chen, X.
    Jiang, J.
    Zhao, P.
    Hou, J.
    Gao, Z.
    Fan, H.
    Ding, J.
    Ren, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S265 - S265
  • [27] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
  • [28] Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
    Rijckborst, Vincent
    Hansen, Bettina E.
    Cakaloglu, Yilmaz
    Ferenci, Peter
    Tabak, Fehmi
    Akdogan, Meral
    Simon, Krzysztof
    Akarca, Ulus S.
    Flisiak, Robert
    Verhey, Elke
    Van Vuuren, Anneke J.
    Boucher, Charles A. B.
    ter Borg, Martijn J.
    Janssen, Harry L. A.
    HEPATOLOGY, 2010, 52 (02) : 454 - 461
  • [29] Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
    Peng, C. -Y.
    Lai, H. -C.
    Li, Y. -F.
    Su, W. -P.
    Chuang, P. -H.
    Kao, J. -T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (04) : 458 - 468
  • [30] A novel baseline prediction model based on HBsAg levels predicts the probability of response to peginterferon alfa in HBeAg-positive chronic hepatitis B
    Sonneveld, Milan J.
    Chan, Henry Lik-Yuen
    Wong, Vincent W.
    Piratvisuth, Teerha
    Jia, Jidong
    Zeuzem, Stefan
    Gane, Edward J.
    Liaw, Yun -Fan
    Xie, Qing
    Janssen, Harry L.
    Hansen, Bettina E.
    HEPATOLOGY, 2013, 58 : 659A - 659A
12345